Perspective: What next for treatment?

Nature. 2016 Sep 15;537(7620):S111. doi: 10.1038/537S111a.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / adverse effects
  • Angiogenesis Inhibitors / therapeutic use
  • Biomarkers, Tumor / genetics
  • Carcinoma, Renal Cell / blood supply
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / genetics
  • Carcinoma, Renal Cell / immunology
  • Disease Progression
  • Early Detection of Cancer
  • Goals*
  • Humans
  • Immunotherapy
  • Kidney Neoplasms / diagnosis*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / immunology
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / genetics
  • Von Hippel-Lindau Tumor Suppressor Protein / genetics

Substances

  • Angiogenesis Inhibitors
  • Biomarkers, Tumor
  • Von Hippel-Lindau Tumor Suppressor Protein
  • VHL protein, human